These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21521647)

  • 21. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.
    Trigo JM; Renoir T; Lanfumey L; Hamon M; Lesch KP; Robledo P; Maldonado R
    Biol Psychiatry; 2007 Sep; 62(6):669-79. PubMed ID: 17306775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. (+/-)-3,4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane.
    Wang X; Baumann MH; Xu H; Morales M; Rothman RB
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1002-12. PubMed ID: 15937150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amitriptyline Accelerates SERT Binding Recovery in a Rat 3,4-Methylenedioxymethamphetamine (MDMA) Model: In Vivo 4-[
    Tsai CJ; Chiu CH; Kuo YY; Huang WS; Yu TH; Flores LG; Yeh SH; Ma KH
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of 3,4-Methylenedioxymethamphetamine.
    Ionescu TM; Amend M; Watabe T; Hatazawa J; Maurer A; Reischl G; Pichler BJ; Wehrl HF; Herfert K
    J Nucl Med; 2023 Mar; 64(3):466-471. PubMed ID: 36175138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extinction training following cocaine or MDMA self-administration produces discrete changes in D
    Frankowska M; Miszkiel J; Pomierny-Chamioło L; Pomierny B; Borelli AC; Suder A; Filip M
    Pharmacol Rep; 2019 Oct; 71(5):870-878. PubMed ID: 31408786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.
    Beardsley PM; Balster RL; Harris LS
    Drug Alcohol Depend; 1986 Oct; 18(2):149-57. PubMed ID: 2877842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of brain SERT occupancy by resveratrol against MDMA-induced neurobiological and behavioral changes in rats: A 4-[¹⁸F]-ADAM/small-animal PET study.
    Shih JH; Ma KH; Chen CF; Cheng CY; Pao LH; Weng SJ; Huang YS; Shiue CY; Yeh MK; Li IH
    Eur Neuropsychopharmacol; 2016 Jan; 26(1):92-104. PubMed ID: 26612383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
    Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
    Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the effects of abstinence on MDMA and cocaine self-administration in rats.
    Highgate Q; Schenk S
    Psychopharmacology (Berl); 2018 Nov; 235(11):3233-3241. PubMed ID: 30209532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.
    Costa G; Morelli M; Simola N
    Neurotox Res; 2017 Nov; 32(4):563-574. PubMed ID: 28597409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
    Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
    Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subanesthetic doses of ketamine transiently decrease serotonin transporter activity: a PET study in conscious monkeys.
    Yamamoto S; Ohba H; Nishiyama S; Harada N; Kakiuchi T; Tsukada H; Domino EF
    Neuropsychopharmacology; 2013 Dec; 38(13):2666-74. PubMed ID: 23880871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of early life stress on [11C]DASB positron emission tomography imaging of serotonin transporters in adolescent peer- and mother-reared rhesus monkeys.
    Ichise M; Vines DC; Gura T; Anderson GM; Suomi SJ; Higley JD; Innis RB
    J Neurosci; 2006 Apr; 26(17):4638-43. PubMed ID: 16641244
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X; Baumann MH; Xu H; Rothman RB
    Synapse; 2004 Sep; 53(4):240-8. PubMed ID: 15266556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of levodopa-induced dyskinesia: Insights from multimodal imaging and immunohistochemistry in non-human primates.
    Beaudoin-Gobert M; Météreau E; Duperrier S; Thobois S; Tremblay L; Sgambato V
    Neuroimage; 2018 Dec; 183():132-141. PubMed ID: 30102999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?
    Fantegrossi WE
    Psychopharmacology (Berl); 2007 Jan; 189(4):471-82. PubMed ID: 16555062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic profile of single and repeated oral doses of MDMA in squirrel monkeys: relationship to lasting effects on brain serotonin neurons.
    Mechan A; Yuan J; Hatzidimitriou G; Irvine RJ; McCann UD; Ricaurte GA
    Neuropsychopharmacology; 2006 Feb; 31(2):339-50. PubMed ID: 15999148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study.
    Kish SJ; Fitzmaurice PS; Chang LJ; Furukawa Y; Tong J
    J Psychopharmacol; 2010 Feb; 24(2):281-4. PubMed ID: 18832433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.